Van Niel
Monique Bodil Van Niel, Essex GB
Patent application number | Description | Published |
---|---|---|
20100144852 | Bicyclo[2.2.1]hept-7-ylamine Derivatives and Their Uses - Compounds of formula (I) have muscarinic M3 receptor modulating activity; Formula (I) wherein A is an oxygen atom or group —N(R | 06-10-2010 |
20110053986 | RESPIRATORY DISEASE TREATMENT - There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation, which composition comprises a glitazone, such as pioglitazone or rosiglitazone, and one or more pharmaceutically acceptable carriers and/or excipients, and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and kit. | 03-03-2011 |
20120264787 | Respiratory Disease Treatment - There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation, which composition comprises a glitazone, such as pioglitazone or rosiglitazone, and one or more pharmaceutically acceptable carriers and/or excipients, and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and kit. | 10-18-2012 |
Monique Bodil Van Niel, Harlow GB
Patent application number | Description | Published |
---|---|---|
20110319446 | BICYCLO[2.2.1]HEPT-7-YLAMINE DERIVATIVES AND THEIR USES - Compounds of formula (I) have muscarinic M3 receptor modulating activity; | 12-29-2011 |
20130143914 | UREA DERIVATIVES AND THEIR THERAPEUTIC USE IN THE TREATMENT OF, INTER ALIA, DISEASES OF THE RESPIRATORY TRACT - Compounds of formula (I) are p38 MAPK inhibitors, useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory wherein R | 06-06-2013 |
20130150343 | KINASE INHIBITORS - Compounds of formula (I) and pharmaceutically acceptable salts thereof: | 06-13-2013 |
20130150361 | KINASE INHIBITORS - Compounds of formula (I): | 06-13-2013 |
20140163024 | BENZYL SULFONAMIDE DERIVATIVES AS RORc MODULATORS - Compounds of the formula Ia or Ib: | 06-12-2014 |
20140275032 | ARYL SULFAMIDE AND SULFAMATE DERIVATIVES AS RORc MODULATORS - Compounds of the formula I: | 09-18-2014 |
20140323470 | KINASE INHIBITORS - Compounds of formula (I) and pharmaceutically acceptable salts thereof: | 10-30-2014 |
20140343055 | KINASE INHIBITORS - Compounds of formula (I): | 11-20-2014 |
20150080375 | KINASE INHIBITORS - Compounds of formula (I) and pharmaceutically acceptable salts thereof: | 03-19-2015 |
Monique Bodil Van Niel, Welwyn GB
Patent application number | Description | Published |
---|---|---|
20090170824 | Diarylsulfones as 5-HT2A Antagonists - Compounds of formula I: | 07-02-2009 |
Monique Bodil Van Niel, Berkshire GB
Patent application number | Description | Published |
---|---|---|
20120088763 | TRIAZOLOPYRIDINE DERIVATIVES AND THEIR THERAPEUTIC USE - Compounds of formula (I) are inhibitors of p38 MAP kinase, useful as anti-inflammatory agents in the treatment of inter alia, diseases of the respiratory tract wherein; R | 04-12-2012 |
Monique Bodil Van Niel, Parma IT
Patent application number | Description | Published |
---|---|---|
20150057273 | KINASE INHIBITORS - Disclosed are compounds having [1,2,4]triazolo[4,3-a]pyridine groups and pharmaceutically acceptable salts thereof. The compounds are p38 MAPK inhibitors, useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract. | 02-26-2015 |